Role of the Gut Microbiome in the Pathophysiology and Treatment of Type 2 Diabetes Mellitus: A Mini Review

Anika Zainab, Arpit Mago, A. Mehmood, Mohamed S. Riad, S. Sonavane
{"title":"Role of the Gut Microbiome in the Pathophysiology and Treatment of Type 2 Diabetes Mellitus: A Mini Review","authors":"Anika Zainab, Arpit Mago, A. Mehmood, Mohamed S. Riad, S. Sonavane","doi":"10.21089/njhs.62.0075","DOIUrl":null,"url":null,"abstract":"Abstract: Introduction: Diabetes mellitus type 2 is a chronic metabolic condition characterized by insulin resistance along with inadequate circulating insulin in the blood. It has been observed that the changes in the complex habitat composed of trillions of bacteria can cause metabolic disturbances. Previous studies have explained the phenomenon of dysbiosis which leads to the development and progression of diabetes mellitus type 2. It has been reported that there are altered gut microbiota levels present in patients with type 2 diabetes mellitus. Main Body: Gut microbiota and its metabolites are involved in the pathogenesis of multiple metabolic diseases including type 2 diabetes mellitus therefore, intestinal microbiota may be one of the crucial medicinal targets for the disease. Studies have shown that diabetes can be managed effectively by altering the human gut microbiome. This review presents three therapeutic options which can be used to alter the gut microbiome. The therapeutic options are; fecal microbial transplant, use of probiotics and cinnamon. These interventions have proven to increase richness and diversity of gut microbiota. A vast number of studies support the beneficial effects of probiotics in treating type 2 diabetes due to its oxidative stress inhibiting properties. Cinnamon has shown similar benefits owing to its anti-inflammatory and anti-oxidative nature. An adequate number of animal studies and few human studies have reported improvement in insulin sensitivity in fecal microbial transplant recipients. Conclusion: Consumption of probiotics and cinnamon have shown potential benefits in the treatment and prevention of type 2 diabetes mellitus. Fecal microbiota transplant has been shown to improve insulin sensitivity along with other impaired characteristics for example HbA1c found in diabetics. It can be suggested that microbiota-based interventions can be used for the prevention and treatment of type 2 diabetes mellitus. Further studies are necessary to explore the mechanisms by which these treatment options provide potential beneficial effects in T2DM patients. Keywords: Gut microbiome, Gut microbiota, Gut flora, Type 2 diabetes mellitus, Fecal microbial transplant, Probiotics.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"138 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"National Journal of Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21089/njhs.62.0075","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: Introduction: Diabetes mellitus type 2 is a chronic metabolic condition characterized by insulin resistance along with inadequate circulating insulin in the blood. It has been observed that the changes in the complex habitat composed of trillions of bacteria can cause metabolic disturbances. Previous studies have explained the phenomenon of dysbiosis which leads to the development and progression of diabetes mellitus type 2. It has been reported that there are altered gut microbiota levels present in patients with type 2 diabetes mellitus. Main Body: Gut microbiota and its metabolites are involved in the pathogenesis of multiple metabolic diseases including type 2 diabetes mellitus therefore, intestinal microbiota may be one of the crucial medicinal targets for the disease. Studies have shown that diabetes can be managed effectively by altering the human gut microbiome. This review presents three therapeutic options which can be used to alter the gut microbiome. The therapeutic options are; fecal microbial transplant, use of probiotics and cinnamon. These interventions have proven to increase richness and diversity of gut microbiota. A vast number of studies support the beneficial effects of probiotics in treating type 2 diabetes due to its oxidative stress inhibiting properties. Cinnamon has shown similar benefits owing to its anti-inflammatory and anti-oxidative nature. An adequate number of animal studies and few human studies have reported improvement in insulin sensitivity in fecal microbial transplant recipients. Conclusion: Consumption of probiotics and cinnamon have shown potential benefits in the treatment and prevention of type 2 diabetes mellitus. Fecal microbiota transplant has been shown to improve insulin sensitivity along with other impaired characteristics for example HbA1c found in diabetics. It can be suggested that microbiota-based interventions can be used for the prevention and treatment of type 2 diabetes mellitus. Further studies are necessary to explore the mechanisms by which these treatment options provide potential beneficial effects in T2DM patients. Keywords: Gut microbiome, Gut microbiota, Gut flora, Type 2 diabetes mellitus, Fecal microbial transplant, Probiotics.
肠道微生物组在2型糖尿病病理生理和治疗中的作用:一个小综述
摘要:2型糖尿病是一种以胰岛素抵抗和血液循环胰岛素不足为特征的慢性代谢疾病。据观察,由数万亿细菌组成的复杂栖息地的变化会引起代谢紊乱。先前的研究已经解释了导致2型糖尿病发生和发展的生态失调现象。据报道,2型糖尿病患者的肠道菌群水平存在改变。肠道菌群及其代谢产物参与了包括2型糖尿病在内的多种代谢性疾病的发病机制,因此肠道菌群可能是2型糖尿病的重要药物靶点之一。研究表明,糖尿病可以通过改变人体肠道微生物群来有效控制。本综述提出了三种可用于改变肠道微生物组的治疗方案。治疗的选择是;粪便微生物移植,使用益生菌和肉桂。这些干预措施已被证明可以增加肠道微生物群的丰富度和多样性。由于其氧化应激抑制特性,大量研究支持益生菌在治疗2型糖尿病中的有益作用。肉桂也有类似的功效,因为它具有抗炎和抗氧化的特性。足够数量的动物研究和很少的人类研究报告了粪便微生物移植接受者胰岛素敏感性的改善。结论:食用益生菌和肉桂对治疗和预防2型糖尿病有潜在的益处。粪便微生物群移植已被证明可以改善胰岛素敏感性以及其他受损特征,例如糖尿病患者的糖化血红蛋白。提示基于微生物群的干预措施可用于2型糖尿病的预防和治疗。需要进一步的研究来探索这些治疗方案对T2DM患者潜在有益作用的机制。关键词:肠道微生物,肠道菌群,肠道菌群,2型糖尿病,粪便微生物移植,益生菌
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信